Description
Angiotensin (1-7), DRVYIHP, an enzymatically produced peptide of the renin-angiotensin system, shows pharmacologically distinct, tissue-specific actions that differ from those of angiotensin II. Angiotensin (1-7) shows considerable cardiovascular and antiangiogenic activity. Iusuf et al. reviewed its phamacological properties and pharmacotherapeutic perspectives. Moreover, the heptapeptide was shown to inhibit the growth of human lung cancer cells in vitro and to reduce the size of human lung cancer xenografts in vivo.
